ASBP Stock Summary and Trading Ideas (Aspire Biopharma Holdings | NASDAQ:ASBP)

Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

Aspire Biopharma Holdings trades on the NASDAQ stock market under the symbol ASBP.

As of August 14, 2026, ASBP stock price climbed to $7.85 with 32,438 million shares trading.

ASBP has a beta of -0.89, meaning it tends to be less sensitive to market movements. ASBP has a correlation of 0.00 to the broad based SPY ETF.

ASBP has a market cap of $10.17 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that ASBP belongs to (by Net Assets): VXF.

ASBP has underperformed the market in the last year with a return of -98.3%, while SPY returned +21.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ASBP shares. However, ASBP has outperformed the market in the last 3 month and 2 week periods, returning +33.7% and +20.4%, while SPY returned +4.0% and +3.9%, respectively. This indicates ASBP has been having a stronger performance recently.

ASBP support price is $6.45 and resistance is $7.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASBP shares will trade within this expected range on the day.